Rutgers Cancer Institute of New Jersey
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://cinj.org
Pharmacists Take Central Role in Managing Novel Cancer Therapies as CAR-T and Bispecific Antibodies Transform Treatment Landscape
Pharmacists have evolved from traditional dispensing roles to comprehensive patient management in cancer care, particularly with novel therapies like CAR-T cell therapy and bispecific antibodies.
FITWISE Trial Explores Tirzepatide's Impact on Weight Loss and Safety in Early-Stage HR+/HER2- Breast Cancer
The FITWISE trial (NCT06518837) is evaluating tirzepatide (Zepbound) for weight loss in patients with early-stage HR+/HER2- breast cancer, assessing its safety and tolerability alongside breast cancer treatments.
© Copyright 2025. All Rights Reserved by MedPath